Gralise Articles
Depomed sues FDA over orphan status exclusivity for Gralise
26 September 2012
Tapentadol ER has advantages over Lyrica in reducing diabetic neuropathy pain intensity
21 March 2012
Depomed regains rights to Gralise from Abbott; licenses Acuform to Boehringer Ingelheim
18 March 2011
US FDA clears use of Novartis’ Menveo for over two-year-olds; Depomed leaps on approval of shingles drug Gralise
31 January 2011
Showing 1-6 of 6 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
